ApoM Suppresses TNF-α-Induced Expression of ICAM-1 and VCAM-1 Through Inhibiting the Activity of NF-κB

被引:25
作者
Gao, Ji-Juan [1 ]
Hu, Yan-Wei [1 ]
Wang, Yan-Chao [1 ]
Sha, Yan-Hua [1 ]
Ma, Xin [2 ]
Li, Shu-Fen [1 ]
Zhao, Jia-Yi [1 ]
Lu, Jing-Bo [3 ]
Huang, Chuan [1 ]
Zhao, Jing-Jing [1 ]
Zheng, Lei [1 ]
Wang, Qian [1 ]
机构
[1] Southern Med Univ, Nanfang Hosp, Lab Med Ctr, Guangzhou 510515, Guangdong, Peoples R China
[2] Southern Med Univ, Nanfang Hosp, Dept Anesthesiol, Guangzhou 510515, Guangdong, Peoples R China
[3] Southern Med Univ, Nanfang Hosp, Dept Vasc Surg, Guangzhou 510515, Guangdong, Peoples R China
关键词
CELL-ADHESION MOLECULE-1; TUMOR-NECROSIS-FACTOR; APOLIPOPROTEIN-M; VASCULAR INFLAMMATION; ACTIVATION; PHOSPHORYLATION; PROTEIN; ATHEROSCLEROSIS; NF-KAPPA-B1; METABOLISM;
D O I
10.1089/dna.2015.2892
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To explore the anti-inflammatory effect of apolipoprotein M (apoM) on regulation of tumor necrosis factor- (TNF-)-induced expression of intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) and further investigate the molecular mechanism of apoM in this process. We found that TNF- could decrease expression of apoM and inhibitor of NF-B- (IB) in HepG2 cells. Overexpression of apoM caused a significant decrease of ICAM-1 and VCAM-1 expression, while it caused a significant increase of IB expression in HepG2 cells. Furthermore, the treatment with TNF- could increase ICAM-1 and VCAM-1 expression, decrease IB protein expression, and increase nuclear factor-B (NF-B) activity, and these effects were markedly enhanced by small interfering RNA (siRNA)-mediated silencing of apoM in HepG2 cells. Our findings demonstrated that apoM suppressed TNF--induced expression of ICAM-1 and VCAM-1 through inhibiting the activity of NF-kappa B.
引用
收藏
页码:550 / 556
页数:7
相关论文
共 44 条
[1]   An ELISA for apolipoprotein M reveals a strong correlation to total cholesterol in human plasma [J].
Axler, Olof ;
Ahnstrom, Josefin ;
Dahlback, Bjorn .
JOURNAL OF LIPID RESEARCH, 2007, 48 (08) :1772-1780
[2]  
BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141
[3]   The transcription factor NF-κB and human disease [J].
Baldwin, AS .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (01) :3-6
[4]   TUMOR-NECROSIS-FACTOR AND INTERLEUKIN-1 LEAD TO PHOSPHORYLATION AND LOSS OF I-KAPPA-B-ALPHA - A MECHANISM FOR NF-KAPPA-B ACTIVATION [J].
BEG, AA ;
FINCO, TS ;
NANTERMET, PV ;
BALDWIN, AS .
MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (06) :3301-3310
[5]   Apolipoprotein M in lipid metabolism and cardiometabolic diseases [J].
Borup, Anna ;
Christensen, Pernille M. ;
Nielsen, Lars B. ;
Christoffersen, Christina .
CURRENT OPINION IN LIPIDOLOGY, 2015, 26 (01) :48-55
[6]   CENTRAL OF I-KAPPA-B-ALPHA PROTEOLYSIS BY SITE-SPECIFIC, SIGNAL-INDUCED PHOSPHORYLATION [J].
BROWN, K ;
GERSTBERGER, S ;
CARLSON, L ;
FRANZOSO, G ;
SIEBENLIST, U .
SCIENCE, 1995, 267 (5203) :1485-1488
[7]   Ageing, tumour necrosis factor-alpha (TNF-α) and atherosclerosis [J].
Bruunsgaard, H ;
Skinhoj, P ;
Pedersen, AN ;
Schroll, M ;
Pedersen, BK .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2000, 121 (02) :255-260
[8]  
CHEN CC, 1995, J IMMUNOL, V155, P3538
[9]   Site-specific phosphorylation of I kappa B alpha by a novel ubiquitination-dependent protein kinase activity [J].
Chen, ZJ ;
Parent, L ;
Maniatis, T .
CELL, 1996, 84 (06) :853-862
[10]  
de Martin R, 2000, ARTERIOSCL THROM VAS, V20, pE83